{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:00:35Z","timestamp":1789002035533,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-07143-z","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T22:24:35Z","timestamp":1731018275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeting protein homeostasis with small molecules as a strategy for the development of pan-coronavirus antiviral therapies"],"prefix":"10.1038","volume":"7","author":[{"given":"Yu-Qian","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Jahanshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Malty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A. J.","family":"Van Ommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor M.","family":"Morey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5391-6050","authenticated-orcid":false,"given":"Stephanie H. W.","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Pavlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choudhary","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subha","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mangos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Nurtanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terek","family":"Been","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7051-8663","authenticated-orcid":false,"given":"Natasha","family":"Christie-Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1477-3616","authenticated-orcid":false,"given":"Scott D.","family":"Gray-Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4118-6406","authenticated-orcid":false,"given":"Mohan","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy P.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8808-7646","authenticated-orcid":false,"given":"Robert A.","family":"Batey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4824-2642","authenticated-orcid":false,"given":"Liliana","family":"Attisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cochrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1861-3441","authenticated-orcid":false,"given":"Walid A.","family":"Houry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"7143_CR1","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. World Health Organization (2023)."},{"key":"7143_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","volume":"7","author":"M Li","year":"2022","unstructured":"Li, M. et al. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct. Target Ther. 7, 146 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"7143_CR3","doi-asserted-by":"crossref","unstructured":"Sabbatucci, M. et al. Omicron variant evolution on vaccines and monoclonal antibodies. Inflammopharmacology 31, 1779\u20131788 (2023).","DOI":"10.1007\/s10787-023-01253-6"},{"key":"7143_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","volume":"22","author":"G Li","year":"2023","unstructured":"Li, G., Hilgenfeld, R., Whitley, R. & De Clercq, E. Therapeutic strategies for COVID-19: progress and lessons learned. Nat. Rev. Drug Discov. 22, 449\u2013475 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"7143_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2023.199131","volume":"332","author":"J Li","year":"2023","unstructured":"Li, J. et al. SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain. Virus Res. 332, 199131 (2023).","journal-title":"Virus Res."},{"key":"7143_CR6","doi-asserted-by":"crossref","unstructured":"Canas, L. S. et al. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations. Lancet Digit Health, (2023).","DOI":"10.1016\/S2589-7500(23)00056-0"},{"key":"7143_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"Coronaviridae Study Group of the International Committee on Taxonomy of V.","year":"2020","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of V. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol 5, 536\u2013544 (2020).","journal-title":"Nat. Microbiol"},{"key":"7143_CR8","first-page":"174","volume":"28","author":"AA Rabaan","year":"2020","unstructured":"Rabaan, A. A. et al. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Infez. Med 28, 174\u2013184 (2020).","journal-title":"Infez. Med"},{"key":"7143_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019Kovski","year":"2021","unstructured":"V\u2019Kovski, P., Kratzel, A., Steiner, S., Stalder, H. & Thiel, V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol 19, 155\u2013170 (2021).","journal-title":"Nat. Rev. Microbiol"},{"key":"7143_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00894-022-05206-8","volume":"28","author":"T Thaingtamtanha","year":"2022","unstructured":"Thaingtamtanha, T. & Baeurle, S. A. Study of protease-mediated processes initiating viral infection and cell-cell viral spreading of SARS-CoV-2. J. Mol. Model 28, 224 (2022).","journal-title":"J. Mol. Model"},{"key":"7143_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fmolb.2017.00058","volume":"4","author":"YQ Mao","year":"2017","unstructured":"Mao, Y. Q. & Houry, W. A. The Role of Pontin and Reptin in cellular physiology and cancer etiology. Front Mol. Biosci. 4, 58 (2017).","journal-title":"Front Mol. Biosci."},{"key":"7143_CR12","doi-asserted-by":"publisher","first-page":"e1007749","DOI":"10.1371\/journal.ppat.1007749","volume":"15","author":"H Katoh","year":"2019","unstructured":"Katoh, H. et al. The R2TP complex regulates paramyxovirus RNA synthesis. PLoS Pathog. 15, e1007749 (2019).","journal-title":"PLoS Pathog."},{"key":"7143_CR13","doi-asserted-by":"crossref","unstructured":"Morwitzer, M. J. et al. Identification of RUVBL1 and RUVBL2 as novel cellular interactors of the Ebola virus nucleoprotein. Viruses 11, 372 (2019).","DOI":"10.3390\/v11040372"},{"key":"7143_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.chom.2015.06.018","volume":"18","author":"X Mu","year":"2015","unstructured":"Mu, X. et al. HIV-1 Exploits the Host Factor RuvB-like 2 to balance viral protein expression. Cell Host Microbe 18, 233\u2013242 (2015).","journal-title":"Cell Host Microbe"},{"key":"7143_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2021.07.003","volume":"66","author":"MF Mabanglo","year":"2022","unstructured":"Mabanglo, M. F., Bhandari, V. & Houry, W. A. Substrates and interactors of the ClpP protease in the mitochondria. Curr. Opin. Chem. Biol. 66, 102078 (2022).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"7143_CR16","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.4049\/jimmunol.2001016","volume":"206","author":"S Torres-Odio","year":"2021","unstructured":"Torres-Odio, S. et al. Loss of Mitochondrial Protease CLPP Activates Type I IFN responses through the mitochondrial DNA-cGAS-STING signaling axis. J. Immunol. 206, 1890\u20131900 (2021).","journal-title":"J. Immunol."},{"key":"7143_CR17","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.chembiol.2011.07.023","volume":"18","author":"E Leung","year":"2011","unstructured":"Leung, E. et al. Activators of cylindrical proteases as antimicrobials: identification and development of small molecule activators of ClpP protease. Chem. Biol. 18, 1167\u20131178 (2011).","journal-title":"Chem. Biol."},{"key":"7143_CR18","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1021\/acsinfecdis.0c00599","volume":"6","author":"G Binepal","year":"2020","unstructured":"Binepal, G. et al. Development of antibiotics that dysregulate the Neisserial ClpP Protease. ACS Infect. Dis. 6, 3224\u20133236 (2020).","journal-title":"ACS Infect. Dis."},{"key":"7143_CR19","doi-asserted-by":"publisher","first-page":"690902","DOI":"10.3389\/fmolb.2021.690902","volume":"8","author":"H Brotz-Oesterhelt","year":"2021","unstructured":"Brotz-Oesterhelt, H. & Vorbach, A. Reprogramming of the Caseinolytic Protease by ADEP Antibiotics: Molecular Mechanism, Cellular Consequences, Therapeutic Potential. Front Mol. Biosci. 8, 690902 (2021).","journal-title":"Front Mol. Biosci."},{"key":"7143_CR20","doi-asserted-by":"publisher","first-page":"74380","DOI":"10.18632\/oncotarget.11814","volume":"7","author":"JE Allen","year":"2016","unstructured":"Allen, J. E. et al. Discovery and clinical introduction of first-in-class imipridone ONC201. Oncotarget 7, 74380\u201374392 (2016).","journal-title":"Oncotarget"},{"key":"7143_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1021\/acschembio.8b00904","volume":"14","author":"VA Assimon","year":"2019","unstructured":"Assimon, V. A. et al. CB-6644 Is a Selective Inhibitor of the RUVBL1\/2 Complex with Anticancer Activity. ACS Chem. Biol. 14, 236\u2013244 (2019).","journal-title":"ACS Chem. Biol."},{"key":"7143_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chembiol.2019.12.005","volume":"27","author":"P Yenerall","year":"2020","unstructured":"Yenerall, P. et al. RUVBL1\/RUVBL2 ATPase activity drives PAQosome maturation, DNA replication and radioresistance in lung cancer. Cell Chem. Biol. 27, 105\u2013121.e114 (2020).","journal-title":"Cell Chem. Biol."},{"key":"7143_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3390\/biom10040605","volume":"10","author":"N Nano","year":"2020","unstructured":"Nano, N. et al. Sorafenib as an Inhibitor of RUVBL2. Biomolecules 10, 605 (2020).","journal-title":"Biomolecules"},{"key":"7143_CR24","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/s41375-023-01971-4","volume":"37","author":"A Hattori","year":"2023","unstructured":"Hattori, A. et al. Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia. Leukemia 37, 1812\u20131829 (2023).","journal-title":"Leukemia"},{"key":"7143_CR25","doi-asserted-by":"crossref","unstructured":"Ju, D. et al. Chemical perturbations reveal that RUVBL2 regulates the circadian phase in mammals. Sci. Transl. Med. 12, eaba0769 (2020).","DOI":"10.1126\/scitranslmed.aba0769"},{"key":"7143_CR26","doi-asserted-by":"publisher","first-page":"12347","DOI":"10.3390\/s120912347","volume":"12","author":"SN Rampersad","year":"2012","unstructured":"Rampersad, S. N. Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors 12, 12347\u201312360 (2012).","journal-title":"Sensors"},{"key":"7143_CR27","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3201\/eid2609.201495","volume":"26","author":"A Banerjee","year":"2020","unstructured":"Banerjee, A. et al. Isolation, sequence, infectivity, and replication kinetics of severe acute respiratory Syndrome Coronavirus 2. Emerg. Infect. Dis. 26, 2054\u20132063 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"7143_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.lfs.2013.09.030","volume":"93","author":"HS Tuli","year":"2013","unstructured":"Tuli, H. S., Sharma, A. K., Sandhu, S. S. & Kashyap, D. Cordycepin: a bioactive metabolite with therapeutic potential. Life Sci. 93, 863\u2013869 (2013).","journal-title":"Life Sci."},{"key":"7143_CR29","first-page":"3824","volume":"37","author":"WE Muller","year":"1977","unstructured":"Muller, W. E. et al. Effect of cordycepin on nucleic acid metabolism in L5178Y cells and on nucleic acid-synthesizing enzyme systems. Cancer Res 37, 3824\u20133833 (1977).","journal-title":"Cancer Res"},{"key":"7143_CR30","doi-asserted-by":"crossref","unstructured":"Radhi, M. et al. A systematic review of the biological effects of Cordycepin. Molecules 26, 5886 (2021).","DOI":"10.3390\/molecules26195886"},{"key":"7143_CR31","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/nm1306","volume":"11","author":"H Brotz-Oesterhelt","year":"2005","unstructured":"Brotz-Oesterhelt, H. et al. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat. Med 11, 1082\u20131087 (2005).","journal-title":"Nat. Med"},{"key":"7143_CR32","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.chembiol.2018.05.014","volume":"25","author":"KS Wong","year":"2018","unstructured":"Wong, K. S. et al. Acyldepsipeptide analogs dysregulate human mitochondrial ClpP protease activity and cause apoptotic cell death. Cell Chem. Biol. 25, 1017\u20131030 e1019 (2018).","journal-title":"Cell Chem. Biol."},{"key":"7143_CR33","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1021\/acschembio.9b00347","volume":"14","author":"KS Wong","year":"2019","unstructured":"Wong, K. S. & Houry, W. A. Chemical modulation of human mitochondrial ClpP: Potential application in cancer therapeutics. ACS Chem. Biol. 14, 2349\u20132360 (2019).","journal-title":"ACS Chem. Biol."},{"key":"7143_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00396-23","volume":"97","author":"S Dahal","year":"2023","unstructured":"Dahal, S. et al. On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine. J. Virol. 97, e0039623 (2023).","journal-title":"J. Virol."},{"key":"7143_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2901-9","volume":"589","author":"Y Han","year":"2021","unstructured":"Han, Y. et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature 589, 270\u2013275 (2021).","journal-title":"Nature"},{"key":"7143_CR36","doi-asserted-by":"publisher","first-page":"e26908","DOI":"10.1371\/journal.pone.0026908","volume":"6","author":"SM Smith","year":"2011","unstructured":"Smith, S. M., Wunder, M. B., Norris, D. A. & Shellman, Y. G. A simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time. PLoS One 6, e26908 (2011).","journal-title":"PLoS One"},{"key":"7143_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2023.109915","volume":"589","author":"S Jahanshahi","year":"2024","unstructured":"Jahanshahi, S. et al. Broad spectrum post-entry inhibitors of coronavirus replication: Cardiotonic steroids and monensin. Virology 589, 109915 (2024).","journal-title":"Virology"},{"key":"7143_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling, D. R. et al. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinforma. 22, 433 (2021).","journal-title":"BMC Bioinforma."},{"key":"7143_CR39","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1093\/bioinformatics\/btab634","volume":"37","author":"DR Stirling","year":"2021","unstructured":"Stirling, D. R., Carpenter, A. E. & Cimini, B. A. CellProfiler Analyst 3.0: accessible data exploration and machine learning for image analysis. Bioinformatics 37, 3992\u20133994 (2021).","journal-title":"Bioinformatics"},{"key":"7143_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0926-6550(63)90054-9","volume":"76","author":"H Klenow","year":"1963","unstructured":"Klenow, H. Formation of the Mono-, Di- and Triphosphate of Cordycepin in Ehrlich Ascites-tumor cells in vitro. Biochim Biophys. Acta 76, 347\u2013353 (1963).","journal-title":"Biochim Biophys. Acta"},{"key":"7143_CR41","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.3390\/molecules26113461","volume":"26","author":"V Daikopoulou","year":"2021","unstructured":"Daikopoulou, V. et al. Targeting SARS-CoV-2 polymerase with new nucleoside analogues. Molecules 26, 3461 (2021).","journal-title":"Molecules"},{"key":"7143_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104541","volume":"169","author":"AJ Brown","year":"2019","unstructured":"Brown, A. J. et al. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antivir. Res. 169, 104541 (2019).","journal-title":"Antivir. Res."},{"key":"7143_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/jcmm.12187","volume":"18","author":"C Wu","year":"2014","unstructured":"Wu, C. et al. Cordycepin activates AMP-activated protein kinase (AMPK) via interaction with the gamma1 subunit. J. Cell Mol. Med 18, 293\u2013304 (2014).","journal-title":"J. Cell Mol. Med"},{"key":"7143_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.chembiol.2020.01.004","volume":"27","author":"SA Hawley","year":"2020","unstructured":"Hawley, S. A. et al. Mechanism of Activation of AMPK by Cordycepin. Cell Chem. Biol. 27, 214\u2013222 e214 (2020).","journal-title":"Cell Chem. Biol."},{"key":"7143_CR45","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1074\/jbc.M109.071159","volume":"285","author":"YY Wong","year":"2010","unstructured":"Wong, Y. Y. et al. Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. J. Biol. Chem. 285, 2610\u20132621 (2010).","journal-title":"J. Biol. Chem."},{"key":"7143_CR46","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1002\/2211-5463.13263","volume":"11","author":"SQ Zuo","year":"2021","unstructured":"Zuo, S. Q. et al. Cordycepin inhibits cell senescence by ameliorating lysosomal dysfunction and inducing autophagy through the AMPK and mTOR-p70S6K pathway. FEBS Open Bio. 11, 2705\u20132714 (2021).","journal-title":"FEBS Open Bio."},{"key":"7143_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03079-4","volume":"11","author":"Y Gao","year":"2020","unstructured":"Gao, Y. et al. Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway. Cell Death Dis. 11, 866 (2020).","journal-title":"Cell Death Dis."},{"key":"7143_CR48","doi-asserted-by":"publisher","first-page":"12778","DOI":"10.3390\/ijms150712778","volume":"15","author":"WD Wu","year":"2014","unstructured":"Wu, W. D. et al. Cordycepin down-regulates multiple drug resistant (MDR)\/HIF-1alpha through regulating AMPK\/mTORC1 signaling in GBC-SD gallbladder cancer cells. Int J. Mol. Sci. 15, 12778\u201312790 (2014).","journal-title":"Int J. Mol. Sci."},{"key":"7143_CR49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","volume":"27","author":"SC Lin","year":"2018","unstructured":"Lin, S. C. & Hardie, D. G. AMPK: Sensing Glucose as well as Cellular Energy Status. Cell Metab. 27, 299\u2013313 (2018).","journal-title":"Cell Metab."},{"key":"7143_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.phrs.2019.03.011","volume":"144","author":"C Wei","year":"2019","unstructured":"Wei, C. et al. Cordycepin inhibits drug-resistance non-small cell lung cancer progression by activating AMPK signaling pathway. Pharm. Res 144, 79\u201389 (2019).","journal-title":"Pharm. Res"},{"key":"7143_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2022.199010","volume":"323","author":"H Parthasarathy","year":"2022","unstructured":"Parthasarathy, H., Tandel, D., Siddiqui, A. H. & Harshan, K. H. Metformin suppresses SARS-CoV-2 in cell culture. Virus Res 323, 199010 (2022).","journal-title":"Virus Res"},{"key":"7143_CR52","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317706915","volume":"39","author":"HL Cao","year":"2017","unstructured":"Cao, H. L., Liu, Z. J. & Chang, Z. Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors. Tumour Biol. 39, 1010428317706915 (2017).","journal-title":"Tumour Biol."},{"key":"7143_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105486","volume":"210","author":"C Kurhade","year":"2023","unstructured":"Kurhade, C., Xie, X. & Shi, P. Y. Reverse genetic systems of SARS-CoV-2 for antiviral research. Antivir. Res 210, 105486 (2023).","journal-title":"Antivir. Res"},{"key":"7143_CR54","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00687-21","volume":"95","author":"HT Nguyen","year":"2021","unstructured":"Nguyen, H. T., Falzarano, D., Gerdts, V. & Liu, Q. Construction of a noninfectious SARS-CoV-2 Replicon for antiviral-drug testing and gene function studies. J. Virol. 95, e0068721 (2021).","journal-title":"J. Virol."},{"key":"7143_CR55","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41392-020-00372-8","volume":"5","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins. Signal Transduct. Target Ther. 5, 269 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"7143_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13578-021-00568-7","volume":"11","author":"JG Lee","year":"2021","unstructured":"Lee, J. G. et al. Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor. Cell Biosci. 11, 58 (2021).","journal-title":"Cell Biosci."},{"key":"7143_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00744-22","volume":"10","author":"FS Shi","year":"2022","unstructured":"Shi, F. S. et al. Expression profile and localization of SARS-CoV-2 nonstructural replicase proteins in infected cells. Microbiol Spectr. 10, e0074422 (2022).","journal-title":"Microbiol Spectr."},{"key":"7143_CR58","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459\u2013468 (2020).","journal-title":"Nature"},{"key":"7143_CR59","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","volume":"384","author":"Consortium WHOST.","year":"2021","unstructured":"Consortium WHOST. et al. Repurposed antiviral drugs for Covid-19 - Interim WHO solidarity trial results. N. Engl. J. Med 384, 497\u2013511 (2021).","journal-title":"N. Engl. J. Med"},{"key":"7143_CR60","doi-asserted-by":"crossref","unstructured":"Sheahan, T. P. et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci. Transl. Med. 12, eabb5883 (2020).","DOI":"10.1126\/scitranslmed.abb5883"},{"key":"7143_CR61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/cimb45010023","volume":"45","author":"EP Zambalde","year":"2023","unstructured":"Zambalde, E. P. et al. Increased mTOR Signaling and Impaired Autophagic Flux Are Hallmarks of SARS-CoV-2 Infection. Curr. Issues Mol. Biol. 45, 327\u2013336 (2023).","journal-title":"Curr. Issues Mol. Biol."},{"key":"7143_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22166-4","volume":"12","author":"PJ Mullen","year":"2021","unstructured":"Mullen, P. J. et al. SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition. Nat. Commun. 12, 1876 (2021).","journal-title":"Nat. Commun."},{"key":"7143_CR63","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1007\/s11033-022-08188-1","volume":"50","author":"T Khalid","year":"2023","unstructured":"Khalid, T. et al. Therapeutic role of mTOR inhibitors in control of SARS-CoV-2 viral replication. Mol. Biol. Rep. 50, 2701\u20132711 (2023).","journal-title":"Mol. Biol. Rep."},{"key":"7143_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106191","volume":"178","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Cordycepin alleviated metabolic inflammation in Western diet-fed mice by targeting intestinal barrier integrity and intestinal flora. Pharm. Res 178, 106191 (2022).","journal-title":"Pharm. Res"},{"key":"7143_CR65","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jfda.2014.01.025","volume":"22","author":"Y Sun","year":"2014","unstructured":"Sun, Y. et al. Regulation of human cytokines by Cordyceps militaris. J. Food Drug Anal. 22, 463\u2013467 (2014).","journal-title":"J. Food Drug Anal."},{"key":"7143_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00894-020-4289-8","volume":"26","author":"J Niramitranon","year":"2020","unstructured":"Niramitranon, J. & Pongprayoon, P. Exploring the binding modes of cordycepin to human adenosine deaminase 1 (ADA1) compared to adenosine and 2\u2019-deoxyadenosine. J. Mol. Model 26, 29 (2020).","journal-title":"J. Mol. Model"},{"key":"7143_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52254-x","volume":"9","author":"JB Lee","year":"2019","unstructured":"Lee, J. B. et al. A novel nucleoside rescue metabolic pathway may be responsible for therapeutic effect of orally administered cordycepin. Sci. Rep. 9, 15760 (2019).","journal-title":"Sci. Rep."},{"key":"7143_CR68","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.3390\/cells10123354","volume":"10","author":"J Key","year":"2021","unstructured":"Key, J. et al. Inactivity of Peptidase ClpP causes primary accumulation of mitochondrial disaggregase ClpX with its interacting nucleoid proteins, and of mtDNA. Cells 10, 3354 (2021).","journal-title":"Cells"},{"key":"7143_CR69","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.3390\/cells11192969","volume":"11","author":"MI Faizan","year":"2022","unstructured":"Faizan, M. I. et al. NSP4 and ORF9b of SARS-CoV-2 induce pro-inflammatory mitochondrial DNA release in inner membrane-derived vesicles. Cells 11, 2969 (2022).","journal-title":"Cells"},{"key":"7143_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102508","volume":"58","author":"SL Archer","year":"2022","unstructured":"Archer, S. L. et al. SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia. Redox Biol. 58, 102508 (2022).","journal-title":"Redox Biol."},{"key":"7143_CR71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","volume":"603","author":"JD Domizio","year":"2022","unstructured":"Domizio, J. D. et al. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature 603, 145\u2013151 (2022).","journal-title":"Nature"},{"key":"7143_CR72","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF01863914","volume":"162","author":"G K\u00e4rber","year":"1931","unstructured":"K\u00e4rber, G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 162, 480\u2013483 (1931).","journal-title":"Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol."},{"key":"7143_CR73","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4939-8678-1_4","volume":"1836","author":"U Karakus","year":"2018","unstructured":"Karakus, U., Crameri, M., Lanz, C. & Yanguez, E. Propagation and titration of influenza viruses. Methods Mol. Biol. 1836, 59\u201388 (2018).","journal-title":"Methods Mol. Biol."},{"key":"7143_CR74","doi-asserted-by":"crossref","unstructured":"Hierholzer J. C., Killington R. A. 2 - Virus isolation and quantitation. In: Virology Methods Manual (ed^(eds Mahy B. W. J., Kangro H. O.). Academic Press (1996).","DOI":"10.1016\/B978-012465330-6\/50003-8"},{"key":"7143_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.341","volume":"2","author":"SY Ngan","year":"2022","unstructured":"Ngan, S. Y. et al. Stage-specific generation of human pluripotent stem cell derived lung models to measure CFTR function. Curr. Protoc. 2, e341 (2022).","journal-title":"Curr. Protoc."},{"key":"7143_CR76","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","volume":"588","author":"Z Ke","year":"2020","unstructured":"Ke, Z. et al. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature 588, 498\u2013502 (2020).","journal-title":"Nature"},{"key":"7143_CR77","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-1-59745-181-9_12","volume":"454","author":"BW Neuman","year":"2008","unstructured":"Neuman, B. W., Adair, B. D., Yeager, M. & Buchmeier, M. J. Purification and electron cryomicroscopy of coronavirus particles. Methods Mol. Biol. 454, 129\u2013136 (2008).","journal-title":"Methods Mol. Biol."},{"key":"7143_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00494-8","volume":"8","author":"S Feng","year":"2017","unstructured":"Feng, S. et al. Improved split fluorescent proteins for endogenous protein labeling. Nat. Commun. 8, 370 (2017).","journal-title":"Nat. Commun."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07143-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07143-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07143-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:02:26Z","timestamp":1731024146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07143-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7143"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-07143-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"17 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1460"}}